节点文献
山莨菪碱的药理和临床研究进展
Advance in pharmacological and clinical research of anisodamine
【摘要】 山莨菪碱与阿托品同属于M胆碱受体拮抗剂。与阿托品相比,山莨菪碱药理作用稍弱,毒副作用也比较低,被广泛用于临床和基础研究。本文主要介绍近年来山莨菪碱药理作用、药动学研究和临床应用方面的进展。
【Abstract】 Anisodamine,like atropine,is a muscarinic receptor antagonist.It appears to be less potent and less adverse reactions than atropine.Anisodamine has been widely used in clinical and basic research.This review focuses on the new developments in pharmacological effects,pharmacokinetics and clinical application of anisodamine.
【关键词】 山莨菪碱;
M受体拮抗剂;
药理;
临床应用;
【Key words】 anisodamine; muscarinic receptor antagonist; pharmacology; clinical application;
【Key words】 anisodamine; muscarinic receptor antagonist; pharmacology; clinical application;
- 【文献出处】 世界临床药物 ,World Clinical Drugs , 编辑部邮箱 ,2010年03期
- 【分类号】R96
- 【被引频次】59
- 【下载频次】1877